See more : Proteonomix, Inc. (PROT) Income Statement Analysis – Financial Results
Complete financial analysis of Medical Care Technologies Inc. (MDCE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medical Care Technologies Inc., a leading company in the Shell Companies industry within the Financial Services sector.
- Repligen Corporation (RGEN) Income Statement Analysis – Financial Results
- Clarim Acquisition Corp. (CLRMU) Income Statement Analysis – Financial Results
- Inner Mongolia Baotou Steel Union Co., Ltd. (600010.SS) Income Statement Analysis – Financial Results
- Le Tanneur & Cie Société anonyme (ALTAN.PA) Income Statement Analysis – Financial Results
- EMX Royalty Corporation (EMX) Income Statement Analysis – Financial Results
Medical Care Technologies Inc. (MDCE)
About Medical Care Technologies Inc.
Medical Care Technologies Inc., a development stage company, engages in opening and operating children's integrated health and wellness centers in China. The company sells and distributes pharmaceutical and nutraceutical products, and other merchandise, including over-the-counter medicines, herbal products, personal care products, and family care products. It serves retail pharmacies, pharmaceutical companies, hospitals, physicians' office practices, and consumers; and industrial and food microbiology laboratories. The company offers its products through its pediatric health and wellness centers, Website, and retail pharmacies, as well as through sales and distribution channels, and directly to end-users through independent sales representatives. Medical Care Technologies Inc. was founded in 2007 and is headquartered in Beijing, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 731.97K | 3.47M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 789.21K | 2.14M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.00K | 494.92K | 0.00 | 0.00 | 0.00 |
| Gross Profit | -57.24K | 1.33M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -10.00K | -494.92K | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | -7.82% | 38.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 323.78K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.43M | 84.36K | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 323.78K | 230.90K | 0.00 | 0.00 | 0.00 | 4.33M | 1.17M | 1.20M | 1.43M | 84.36K | 5.98K | 22.04K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 323.78K | 230.90K | 0.00 | 0.00 | 0.00 | 4.33M | 1.17M | 1.21M | 1.94M | 84.36K | 5.98K | 37.54K |
| Cost & Expenses | 1.11M | 2.37M | 0.00 | 0.00 | 0.00 | 4.33M | 1.17M | 1.21M | 1.94M | 84.36K | 5.98K | 37.54K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 6.49K | 0.00 | 0.00 | 0.00 | 0.00 | 25.11K | 414.25K | 487.17K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 381.02K | 228.49K | 236.56K | 206.30K | 171.86K | 0.00 | 0.00 | 10.00K | 516.93K | 0.00 | 0.00 | 0.00 |
| EBITDA | 0.00 | 1.10M | 0.00 | 0.00 | 0.00 | -4.33M | -2.36M | -1.44M | -1.69M | -85.12K | -5.98K | -37.54K |
| EBITDA Ratio | 0.00% | 31.69% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -381.02K | 1.10M | 0.00 | 0.00 | 0.00 | -4.33M | -1.17M | -978.17K | -1.94M | -83.59K | -5.98K | -37.54K |
| Operating Income Ratio | -52.05% | 31.69% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -6.49K | -5.00 | 0.00 | 0.00 | 0.00 | -25.13K | -1.60M | 0.00 | 1.78K | -764.00 | 0.00 | 0.00 |
| Income Before Tax | -387.51K | 1.10M | 0.00 | 0.00 | 0.00 | -4.36M | -2.77M | -1.21M | -1.94M | -84.36K | 0.00 | 0.00 |
| Income Before Tax Ratio | -52.94% | 31.69% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -228.49K | 0.00 | 0.00 | 0.00 | 0.00 | -9.97K | 716.11K | -1.78K | 764.00 | 55.74K | 37.54K |
| Net Income | -387.51K | 1.10M | 0.00 | 0.00 | 0.00 | -4.36M | -2.76M | -1.92M | -1.94M | -85.12K | -55.74K | -37.54K |
| Net Income Ratio | -52.94% | 31.69% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -4.83 | -2.82K | -12.49K | -24.25K | -1.74K | -1.14K | -20.00K |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -4.83 | -2.82K | -12.49K | -24.25K | -1.74K | -1.14K | -20.00K |
| Weighted Avg Shares Out | 3.23B | 3.21B | 2.96B | 2.96B | 2.96B | 901.92K | 981.14 | 154.00 | 80.00 | 49.00 | 49.00 | 0.00 |
| Weighted Avg Shares Out (Dil) | 3.21B | 3.21B | 2.96B | 2.96B | 2.96B | 901.92K | 981.14 | 154.00 | 80.00 | 49.00 | 49.00 | 0.00 |
ONWARD® Medical Successfully Raises EUR 50 Million in an Upsized Capital Increase with Cornerstone Investment from Ottobock SE & Co. KGaA
MDCE / Infinite Auctions (OTC PINK: MDCE) Initiates Plan to Incrementally Reduce the Outstanding Share Count by Slashing 200 Million Shares in phase one and explains the Benefits of funding plan.
MDCE / Infinite Auctions Enters Partnership with Leading Music and Entertainment Auction House to Scale and Expand Operations.
MDCE / Infinite Auctions Announces Rising Auction Results with Over $250,000 in Sales at 2024 Summer Premier Auction, Showcasing Robust Demand
Swiss National Bank Lowers Stock Position in ICU Medical, Inc. (NASDAQ:ICUI)
Infinite Auctions / Medical Care Technologies (OTC Pink: MDCE) Celebrates Investor Support with Ambitious 2024 Plans
Source: https://incomestatements.info
Category: Stock Reports